StockStory.org on MSN2 天
Patient Monitoring Stocks Q4 In Review: Insulet (NASDAQ:PODD) Vs PeersLet’s dig into the relative performance of Insulet (NASDAQ:PODD) and its peers as we unravel the now-completed Q4 patient ...
Below is Validea's guru fundamental report for INSULET CORP (PODD). Of the 22 guru strategies we follow, PODD rates highest using our Twin Momentum Investor model based on the published strategy ...
Insulet Corporation PODD reported fourth-quarter 2024 adjusted earnings per share (EPS) of $1.15, down significantly 17.8% from the year-ago period’s figure. The bottom line surpassed the Zacks ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果